ETRetailMotilal Oswal has buy call on Hindustan Unilever with a target price of Rs 2780. The current market price of is Rs 2431.65. Time period given by analyst is one year when Hindustan Unilever Ltd. price can reach defined target.
Hindustan Unilever Ltd., incorporated in the year 1933, is a Large Cap company (having a market cap of Rs 568055.01 Crore) operating in FMCG sector.
Financials
For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 12542.00 Crore, up 2.51 % from last quarter Total Income of Rs 12235.00 Crore and up 32.37 % from last year same quarter Total Income of Rs 9475.00 Crore. Company reported net profit after tax of Rs 2191.00 Crore in latest quarter.
Investment Rationale
HUVR’s best-of-breed analytics and execution capabilities (demonstrated via the successful implementation of its WIMI strategy, cost-saving plans, herbals, etc.) are key factors driving the pace of earnings growth. The strong outlook on rural, GSKCH synergies, and sustained growth and premiumization in Skin Cleansing offer further medium-term tailwinds.
Promoter/FII Holdings
Promoters held 61.9 per cent stake in the company as of March 31, 2021, while FIIs held 15 per cent, DIIs 10.7 per cent and public and others 12.5 per cent.
Hindustan Unilever Ltd., incorporated in the year 1933, is a Large Cap company (having a market cap of Rs 568055.01 Crore) operating in FMCG sector.
Financials
For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 12542.00 Crore, up 2.51 % from last quarter Total Income of Rs 12235.00 Crore and up 32.37 % from last year same quarter Total Income of Rs 9475.00 Crore. Company reported net profit after tax of Rs 2191.00 Crore in latest quarter.
Did you Know?
Stock score of Hindustan Unilever Ltd moved down by 1 in a month.
View Latest Stock Report »Investment Rationale
HUVR’s best-of-breed analytics and execution capabilities (demonstrated via the successful implementation of its WIMI strategy, cost-saving plans, herbals, etc.) are key factors driving the pace of earnings growth. The strong outlook on rural, GSKCH synergies, and sustained growth and premiumization in Skin Cleansing offer further medium-term tailwinds.
Promoter/FII Holdings
Promoters held 61.9 per cent stake in the company as of March 31, 2021, while FIIs held 15 per cent, DIIs 10.7 per cent and public and others 12.5 per cent.
(Disclaimer: Views and recommendations given in this section are the analysts' own and do not represent those of ETMarkets.com. Please consult your financial adviser before taking any position in the stock/s mentioned.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
